Status:
RECRUITING
Biomarkers in Prediction of AMI
Lead Sponsor:
University of Tartu
Conditions:
Acute Mesenteric Ischemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Dif...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Initial decision in favour of further diagnostics of mesenteric ischaemia
Exclusion
- Age \<18 years
- Consent declined by patient or next of kin (delayed consent)
- Chronic mesenteric ischaemia without an acute event
- Immediate decision for withdrawal of further diagnostics and active treatment
- Referral from another hospital with already established diagnosis of AMI
- AMI diagnosed at surgery without previously having been considered
Key Trial Info
Start Date :
October 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06212921
Start Date
October 14 2024
End Date
December 1 2025
Last Update
December 3 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tartu University Hospital
Tartu, Estonia, 50406
2
Lucerne Cantonal Hospital
Lucerne, Switzerland, 6000